English
Русский
简体中文
Português (Brasil)
Kazakh
Eco-vector
Pharmateca
ISSN 2073-4034 (Print) ISSN 2414-9128 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • Editorial Board
  • All Journals
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus gastroesophageal reflux disease insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke type 2 diabetes mellitus vitamin D
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus gastroesophageal reflux disease insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke type 2 diabetes mellitus vitamin D
Home > Search > Author Details

Author Details

Lubennikova, E. V

Issue Section Title File
No 8 (2014) Articles DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
No 18 (2015) Articles 15-letniy opyt ispol'zovaniya Gertseptina pri HER2-pozitivnom rake molochnoy zhelezy
No 8 (2017) Articles Ixempra - new possibilities of cytostatic therapy of breast cancer
Vol 28, No 7 (2021) Articles Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Vol 28, No 7 (2021) Articles Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
 

JOURNALS

Journal list

Search Articles

Manuscript submission

Services for Authors

LEGAL INFORMATION

User's personal data processing consent

Privacy statement

End user license agreement

Policy on distribution of notifications and marketing information

INFORMATION

Publisher's Blog

SERVICES

Subscription

Advertisement

Help with the site

CONTACTS Eco-Vector

Aptekarskiy per, d. 3, lit. A, office 1H, 191181 Saint-Petersburg, Russia

Phone: +7 (812) 648 8367

Email: info@eco-vector.com

SUBSCRIPTION

Phone: +7 (495) 409 8339

Email: podpiska@eco-vector.com

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP